These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33331867)

  • 1. Bringing evidence from press release to the clinic in the era of COVID-19.
    McMahon JH; Lydeamore MJ; Stewardson AJ
    J Antimicrob Chemother; 2021 Feb; 76(3):547-549. PubMed ID: 33331867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.].
    Koch M
    Recenti Prog Med; 2021 Jan; 112(1):15-18. PubMed ID: 33512353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reimagining the peer-review system for translational health science journals.
    Smith EM
    Clin Transl Sci; 2021 Jul; 14(4):1210-1221. PubMed ID: 33963670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States : A Retrospective Cohort Study.
    Mehta HB; An H; Andersen KM; Mansour O; Madhira V; Rashidi ES; Bates B; Setoguchi S; Joseph C; Kocis PT; Moffitt R; Bennett TD; Chute CG; Garibaldi BT; Alexander GC;
    Ann Intern Med; 2021 Oct; 174(10):1395-1403. PubMed ID: 34399060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options for COVID-19: a quick review.
    Ismaila MS; Bande F; Ishaka A; Sani AA; Georges K
    J Chemother; 2021 Apr; 33(2):67-84. PubMed ID: 33427110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 pharmacologic therapies and their safety/effectiveness according to level of evidence.
    Baroutjian A; Sanchez C; Boneva D; McKenney M; Elkbuli A
    Am J Emerg Med; 2020 Nov; 38(11):2405-2415. PubMed ID: 33041111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.
    Moneer O; Daly G; Skydel JJ; Nyhan K; Lurie P; Ross JS; Wallach JD
    BMJ; 2022 May; 377():e069400. PubMed ID: 35537738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.
    Mainoli B; Machado T; Duarte GS; Prada L; Gonçalves N; Ferreira JJ; Costa J
    BMC Med Res Methodol; 2021 Feb; 21(1):42. PubMed ID: 33637044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social Media and Research Publication Activity During Early Stages of the COVID-19 Pandemic: Longitudinal Trend Analysis.
    Taneja SL; Passi M; Bhattacharya S; Schueler SA; Gurram S; Koh C
    J Med Internet Res; 2021 Jun; 23(6):e26956. PubMed ID: 33974550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How COVID broke the evidence pipeline.
    Pearson H
    Nature; 2021 May; 593(7858):182-185. PubMed ID: 33981057
    [No Abstract]   [Full Text] [Related]  

  • 11. Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
    Lilli C; Biggeri A; Zingaretti C; Vertogen B; Frassineti V; Vespignani R; Grossi V; Florescu C; Matteucci L; Pazzi C; Bongiovanni A; Limarzi F; Fausti V; Bertoni L; Donati C; Galardi F; Gentili N; Mazza F; Martinelli G; Nanni O
    Epidemiol Prev; 2021; 45(1-2):28-36. PubMed ID: 33884840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rise of the preprint: how rapid data sharing during COVID-19 has changed science forever.
    Watson C
    Nat Med; 2022 Jan; 28(1):2-5. PubMed ID: 35031791
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of pharmacological interventions in COVID-19: A network meta-analysis.
    Selvarajan S; Anandaradje A; Shivabasappa S; Melepurakkal Sadanandan D; Nair NS; George M
    Br J Clin Pharmacol; 2022 Sep; 88(9):4080-4091. PubMed ID: 35357033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine for the treatment of COVID-19: the importance of scrutiny of positive trials.
    Chow R; Simone CB; Lock M
    Ann Palliat Med; 2020 Nov; 9(6):3716-3720. PubMed ID: 32921099
    [No Abstract]   [Full Text] [Related]  

  • 19. Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    White NJ; Strub-Wourgaft N; Faiz A; Guerin PJ
    Lancet; 2021 Apr; 397(10281):1262-1263. PubMed ID: 33765411
    [No Abstract]   [Full Text] [Related]  

  • 20. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.